Sale!

DMD BMD Mutation Screening 26 Exons Prenatal Test Cost

Original price was: 2,800 د.إ.Current price is: 2,100 د.إ.

-25%

The “DMD BMD Mutation Screening 26 Exons Prenatal Test” is a specialized genetic test offered by DNA Labs UAE, designed to screen for mutations in 26 specific exons of the DMD gene, which are crucial for diagnosing Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). These conditions are inherited disorders characterized by progressive muscle degeneration and weakness, with DMD presenting more severe symptoms than BMD. Early detection through prenatal testing is vital for families with a history of these disorders, as it can provide essential information for medical management and planning. The test is priced at 2100 AED, reflecting the advanced technology and expertise required to accurately identify the presence of mutations in these critical regions of the DMD gene. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, this test offers expectant parents peace of mind and the opportunity to prepare for the needs of their child.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DMDBMD Mutation Screening 26 Exons Prenatal Test

At DNA Labs UAE, we offer the DMDBMD mutation screening 26 exons prenatal test. This test helps in analyzing the 26 exons of the DMD (Duchenne muscular dystrophy) or BMD (Becker muscular dystrophy) genes. These two types of muscular dystrophy are caused by mutations in the DMD gene, which codes for a protein called dystrophin.

Test Details

The DMDBMD mutation screening 26 exons prenatal test involves obtaining a sample of fetal DNA, usually through chorionic villus sampling (CVS) or amniocentesis. The DNA is then analyzed to identify any mutations in the DMD gene. This screening test can detect a wide range of mutations, including small deletions, duplications, insertions, and point mutations.

The purpose of this test is to determine if the fetus has inherited a mutation in the DMD gene. If a mutation is detected, it indicates an increased risk of the fetus developing Duchenne or Becker muscular dystrophy. However, it is important to note that the presence of a mutation does not guarantee that the fetus will develop the condition, as the severity of the disease can vary.

This screening test is typically offered to couples who have a family history of Duchenne or Becker muscular dystrophy, or if there is a known carrier in either parent. It can provide valuable information for parents, allowing them to make informed decisions about their pregnancy and to prepare for the possibility of having a child with muscular dystrophy.

Test Components

  • Sterile container
  • Sterile Normal Saline Container
  • EDTA Vacutainer (2ml)

Price

AED 2100.0

Sample Condition

Amniotic fluid / Chorionic villi / Cord blood

Report Delivery

4-5 days

Method

Multiplex End Point PCR

Test Type

Genetics

Doctor

General Physician

Test Department

Pre Test Information

DMD/BMD mutation screening (26 exons) Prenatal can be done with a doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Consult a Healthcare Professional

It is important to consult with a healthcare professional or genetic counselor to understand the specific implications and limitations of DMD/BMD mutation screening, as well as to discuss any concerns or questions regarding the test.

Test Name DMDBMD mutation screening 26 exons Prenatal Test
Components Sterile container / Sterile Normal Saline Container / EDTA Vacutainer (2ml)
Price 2100.0 AED
Sample Condition Amniotic fluid\/ Chorionic villi\/ Cord blood
Report Delivery 4-5 days
Method Multiplex End Point PCR
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information DMD/BMD mutation screening (26 exons) Prenatal] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

DMD/BMD mutation screening is a prenatal test that involves analyzing the 26 exons of the DMD (Duchenne muscular dystrophy) or BMD (Becker muscular dystrophy) genes. These two types of muscular dystrophy are caused by mutations in the DMD gene, which codes for a protein called dystrophin.

During the test, a sample of fetal DNA is obtained, usually through chorionic villus sampling (CVS) or amniocentesis. The DNA is then analyzed to identify any mutations in the DMD gene. This screening test can detect a wide range of mutations, including small deletions, duplications, insertions, and point mutations.

The purpose of DMD/BMD mutation screening is to determine if the fetus has inherited a mutation in the DMD gene. If a mutation is detected, it indicates an increased risk of the fetus developing Duchenne or Becker muscular dystrophy. However, it is important to note that the presence of a mutation does not guarantee that the fetus will develop the condition, as the severity of the disease can vary.

This screening test is typically offered to couples who have a family history of Duchenne or Becker muscular dystrophy, or if there is a known carrier in either parent. It can provide valuable information for parents, allowing them to make informed decisions about their pregnancy and to prepare for the possibility of having a child with muscular dystrophy.

It is important to consult with a healthcare professional or genetic counselor to understand the specific implications and limitations of DMD/BMD mutation screening, as well as to discuss any concerns or questions regarding the test.